|
Volumn 20, Issue 4, 2000, Pages 223-228
|
Clinical efficacy of inhaled zanamivir for the treatment of patients with influenza B virus infection: A pooled analysis of randomised, placebo-controlled studies
a b c d e e |
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
SIALIDASE INHIBITOR;
ZANAMIVIR;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A;
INFLUENZA VIRUS B;
MAJOR CLINICAL STUDY;
MALE;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
SYMPTOMATOLOGY;
|
EID: 0033761421
PISSN: 11732563
EISSN: None
Source Type: Journal
DOI: 10.2165/00044011-200020040-00003 Document Type: Article |
Times cited : (7)
|
References (5)
|